Glossary
Description
we, us, our
Avantor, Inc. and its subsidiaries
Legacy Avantor Plan
the Avantor Funding, Inc. (f/k/a Avantor, Inc.) Equity Incentive Plan
Vail Plan
the Avantor, Inc. (f/k/a Vail Holdco Corp) Equity Incentive Plan
2019 Plan
the Avantor, Inc. 2019 Equity Incentive Plan
AMEA
Asia, Middle-East and Africa
AOCI
accumulated other comprehensive income or loss
APAC
Asia Pacific
BIS
the Bureau of Industry and Security
CERCLA
the Comprehensive Environmental Response Compensation and Liability Act
cGMP
Current Good Manufacturing Practice
DDTC
Directorate of Defense Trade controls
DEA
Drug Enforcement Administration
DHHS
Department of Health and Human Service
EMA
European Medicines Agency
EPA
the U.S. Environmental Protection Agency
ERP
enterprise resource planning system
EU
European Union
EURIBOR
the basic rate of interest used in lending between banks on the European Union interbank market
FASB
the Financial Accounting Standards Board of the United States
FCPA
the United States Foreign Corrupt Practices Act
FDA
United States Food and Drug Administration
GAAP
United States generally accepted accounting principles
GDPR
the General Data Protection Regulation
Goldman Sachs
an investment banking firm and its affiliates
high single-digit
7 - 9%
IPO
initial public offering
ISO
International Organization for Standardization or international equivalents
ITAR
the International Traffic In Arms Regulations
ii
LIBOR
the basic rate of interest used in lending between banks on the London interbank market
low double-digit
10 - 19%
low single-digit
1 - 3%
Management EBITDA
earnings before interest, income taxes, depreciation, amortization and certain other items, our segment profitability measurement under GAAP
MCPS
6.250% Series A Mandatory Convertible Preferred Stock
mid single-digit
4 - 6%
NCI
noncontrolling interest
New Mountain Capital
a private equity investor and its affiliates
NuSil
NuSil Acquisition Corp, NuSil Investments LLC and subsidiaries, a business organization with which we merged in 2016
NuSil Investors
NuSil LLC and NuSil 2.0 LLC, former owners of NuSil that are controlled by its former management
NYSE
the New York Stock Exchange
OFAC
the U.S. Department of The Treasury’s Office of Foreign Assets Control
OSHA
the U.S. Occupational Safety & Health Administration
PSP Investments
a pension investment manager and its affiliates
Registration Statement
our registration statement on Form S-1 (File No. 333-229578), as amended
RSU
restricted stock unit
SAR
stand alone appreciation right
SEC
the United States Securities and Exchange Commission
SG&A expenses
selling, general and administrative expenses
specialty procurement
product sales related to customer procurement services
VWR
VWR Corporation and its subsidiaries, a company we acquired in November 2017
iii
Cautionary factors regarding forward-looking statements
This report contains forward-looking statements. All statements other than statements of historical fact included in this report are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. These statements may be preceded by, followed by or include the words “aim,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “likely,” “outlook,” “plan,” “potential,” “project,” “projection,” “seek,” “can,” “could,” “may,” “should,” “would,” “will,” the negatives thereof and other words and terms of similar meaning.
Forward-looking statements are inherently subject to risks, uncertainties and assumptions; they are not guarantees of performance. You should not place undue reliance on these statements. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that our assumptions made in connection with the forward-looking statements are reasonable, we cannot assure you that the assumptions and expectations will prove to be correct.
You should understand that the following important factors, in addition to those discussed under Item 1A, “Risk Factors,” could affect our future results and could cause those results or other outcomes to differ materially from those expressed or implied in our forward-looking statements: